加载中
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
常规交易时段
US$27.83
−US$0.10 · -0.36%
盘中时间采用ET。市场数据可能有所延迟。
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
日内区间
当前US$27.83
52周区间
当前US$27.83
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
77
低估
情绪
60
多空交织
风险
25
中等风险
动量
67
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
日内区间
当前US$27.83
52周区间
当前US$27.83
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 12.89亿 USD | 11.67亿 USD | 10.89亿 USD | 7.87亿 USD | 5.01亿 USD |
| 销货成本 | 9.84亿 USD | 9.14亿 USD | 8.5亿 USD | 6.2亿 USD | 3.88亿 USD |
| 毛利 | 3.04亿 USD | 2.53亿 USD | 2.39亿 USD | 1.67亿 USD | 1.12亿 USD |
| 销售、一般及管理费用 | 2.19亿 USD | 1.86亿 USD | 1.77亿 USD | 1.44亿 USD | 7979.5万 USD |
| 营业费用 | 2.19亿 USD | 1.86亿 USD | 1.77亿 USD | 1.44亿 USD | 7979.5万 USD |
| 利息收入 | 1015.5万 USD | 1574.7万 USD | 850.7万 USD | 81.4万 USD | 46.1万 USD |
| 折旧和摊销 | 494.8万 USD | 317.5万 USD | 228.1万 USD | 160.1万 USD | 130.1万 USD |
| 营业利润 | 8527.7万 USD | 6745.5万 USD | 6218.4万 USD | 2334.1万 USD | 3234万 USD |
| 净利润 | 5852万 USD | 5433.6万 USD | 6203.7万 USD | 3035.8万 USD | 6576.9万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$35.50
上涨空间 27.56%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI5756.11万0.00%2.3万亿 USD0.03%US$381.66-0.07%
Avantis U.S. Small Cap Value ETFAVUV5381.68万0.17%308.51亿 USD0.25%US$120.14+0.42%
iShares Russell 2000 ETFIWM5358.08万0.07%787.4亿 USD0.19%US$278.46-0.17%
Vanguard Morningstar Small-Cap ETFVB4144.85万0.02%1853亿 USD0.03%US$288.95-0.18%
Vanguard Morningstar Small-Cap Growth ETFVBK2391.62万0.05%447亿 USD0.05%US$341.89-0.83%
Vanguard Extended Market ETFVXF2169.56万0.02%954亿 USD0.05%US$234.23-0.33%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1959.25万0.12%158.4亿 USD0.03%US$53.53+0.15%
iShares Russell 2000 Growth ETFIWO1896.27万0.14%139.17亿 USD0.24%US$354.87-0.54%Vanguard Morningstar Total Stock Market ETFVTIAvantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMiShares Russell 2000 Growth ETFIWOAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
